Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-16-007977

Options or other derivatives

  • Chief Executive Officer acquired 16,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Carpenter George C IV Chief Executive Officer 2016-11-01 Grant or award · Employee Stock Option (right to purchase) +16,000 16,000 D
Loading xslF345X03/s104516_form4.xml…